Streptococcus suis meningoencephalitis diagnosed with metagenomic next-generation sequencing: A case report with literature review

J Infect Chemother. 2024 Jun;30(6):544-547. doi: 10.1016/j.jiac.2023.11.017. Epub 2023 Nov 21.

Abstract

Streptococcus suis is a pathogen of emerging zoonotic diseases and meningoencephalitis is the most frequent clinical symptom of S. suis infection in humans. Rapid diagnosis of S. suis meningoencephalitis is critical for the treatment of the disease. While the current routine microbiological tests including bacterial culture and gram staining are poorly sensitive, diagnosis of S. suis meningoencephalitis by metagenomic next-generation sequencing (mNGS) has been rarely reported. Here, we report a 52-year-old female pork food producer with a broken finger developed S. suis meningoencephalitis. After her admission, no pathogenic bacteria were detected through bacterial culture and Gram staining microscopy in the cerebrospinal fluid obtained via lumbar puncture. However, mNGS identified the presence of S. suis in the sample. mNGS is a promising diagnostic tool for rapid diagnosis of rare infectious diseases in the central nervous system.

Keywords: Cerebrospinal fluid; Meningoencephalitis; Metagenomic next-generation sequencing; Streptococcus suis.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Animals
  • Female
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Meningoencephalitis* / diagnosis
  • Meningoencephalitis* / drug therapy
  • Middle Aged
  • Streptococcal Infections* / microbiology
  • Streptococcus suis* / genetics
  • Zoonoses / diagnosis
  • Zoonoses / drug therapy
  • Zoonoses / microbiology